Detalles de la búsqueda
1.
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
Am J Hematol
; 99(4): 763-766, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38317312
2.
Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice.
Leuk Lymphoma
; 62(1): 194-202, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33021423
3.
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.
Leukemia
; 38(4): 893-897, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472478
4.
Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients - results from real-life prospective study.
Leuk Lymphoma
; 61(2): 494-496, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31580157
Resultados
1 -
4
de 4
1
Próxima >
>>